Key Considerations for Developing
Cell-Based Assays 

In this complimentary webinar, Dr. Danielle Salha, Senior Director, Immunochemistry and Immunology, Ligand Binding Assays, discusses key parameters to consider during method development to support drug potency and immunogenicity characterization. 

Topics covered:

• Reducing development timelines and management of critical reagents
• Important parameters to consider for NAb method development and for the development of potency assays
• Management of critical reagents to support long-term clinical studies
• Advantages of using the same method for both immunogenicity assessment and product characterization
• Challenges that may be encountered when developing cell-based assays

Watch now

You may also be interested in the following:

• Ligand Binding Capabilities
• Bioanalytical Assay List
• The Altascientist — Validation of Immunogenicity Assays

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

It’s All About ASOs!

Antisense oligonucleotides (ASOs) offer an exciting pathway to targeting the source of a disease’s pathogenesis. In this e-book, we take a deep dive into the bioanalytical development for the analysis of ASOs.

Topics covered: 

• Benefits and challenges of novel ASO bioanalytical approaches.
• Case studies examining how best to align a bioanalytical technique with the goals of a particular ASO drug development program. 

Download the FREE e-book now

Speak with an expert.

Have 5 minutes? Take a look at these:

• Comprehensive Bioanalytical Services
• Altasciences' Proprietary Bioanalytical Assay List
• Three Laboratories – One Vision (PODCAST)

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Nonclinical and Clinical Research Services — Phase I to IV

Whether you are looking for a full-service solution or a stand-alone offering, Altasciences will help guide you along the way. We are accustomed to managing complex projects with different partners, and have robust communication and operational processes in place to ensure efficient integration.

We offer a range of services for early phase and late phase studies, including:

• Program Management
• Clinical Monitoring
• Scientific Publication Development and Review
• Protocol Development and Medical Writing
• PK/PD Analysis and Interpretation
• Data Management
• Biostatistics and Statistical Analysis
• Support Services for Non-Clinical Studies

Have 5 minutes? You may be interested in this:

• Clinical Trial Services
• Podcast — Choosing the Right CRO for Your Clinical Trial Monitoring
• Blog — Five Things You Need to Know About Partnering with an Integrated CRO/CDMO

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Combining Trial Conduct and Bioanalysis for Success

Combining Phase I trial conduct of biologics and bioanalysis is critical for successful drug development. Clinical development relies heavily on bioanalytical experts to generate critical data to understand pharmacokinetics and pharmacodynamics. 

Here are just some of the benefits of working with Altasciences:

• Timed interim sample analysis for dose escalation decisions
• Rapid turnaround of PK/PD analysis between cohorts 
• Biomarker development and validation for exploratory or primary endpoints
• Proximity flow cytometry 
• Centralized scheduling between clinic and lab
• Ability to easily switch or combine platforms which are sensitive, have high throughput, and demonstrate exquisite specificity

Watch this complimentary webinar to see how you can overcome challenges throughout all phases of drug development.

Watch webinar

Have 5 minutes? Take a look at these:

• How Is Partnering with Altasciences for Your First-in-Human Clinical Trials Different?
• Microsampling in Drug Development
• Validated Bioanalytical Assay List

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Sample Management Based on Your Specific Needs

Did you know that Altasciences’ Material Management Team has over 25 years of experience? Indeed, our experts in sample management processes have been supporting clinical trials worldwide for over two decades. 

We have designed an efficient system for accurate and safe clinical sample preparation, collection, and shipment from trial sites to bioanalytical laboratories. 

Watch to learn more.

Questions about our customized offering? Send us a message. 

You may also be interested in:

• Clinical Sample Collection Kits Capabilities
• Bioanalytical Services
• Clinical Services

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

From discovery to preclinical to Phase IV, Altasciences’ bioanalytical team of over 260 scientific experts specialized in bioanalysis, ligand binding assays (LBA), mass spectrometry, immunology, biomarkers, flow cytometry, and PCR, operates in three strategic locations in proximity to our preclinical and clinical sites. We aim to provide top quality data for TK, PK, and PD determinations to support your preclinical and clinical studies.   

At Altasciences, One Laboratory Sciences moves in unison for the success and acceleration of drug development.

Let’s schedule time to discuss your bioanalytical needs.


You may also be interested in the following:

• Podcast — Three Laboratories - One Vision, with Dr. Lynne Le Sauteur
• Webinar — Managing Challenging Bioanalysis for PK/PD Assessments for Phase I Biologics
• Video — Take a Look Inside our PCR Lab
• Press Release — Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Our clinical trial experts set your drug development program up for success by proactively preparing and performing each critical moving part while others are underway. As a single source for early phase drug development solutions, we integrate and synchronize key CRO/CDMO activities, such as clinic-ready manufacturing, bioanalysis, clinical study conduct, and regulatory review, so that you’re always ready for the next step.

Check out how we do this and experience the difference.  

You may also be interested in the following:

Webpages:

• Proactive Drug Development
• First-in-Human Trials

Fact Sheet:

• Comprehensive Research Support

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.